Ready-to-use biosimilars

We provide qualitative target product profiling, process development, head-to-head comparability studies, process characterization and impurity profiling with continuous quality assurance supervision throughout the entire development process.

Profarma has established technologies for:

  • Ranibizumab
  • Human growth hormone (hGH)
  • Granulocyte colony stimulating factor (G-CSF)
  • Granulocyte macrophage colony stimulating factor (GM-CSF)
  • Stem cell factor (SCF)
  • Interferon α-2a
  • Interferon α-2b

All technologies are available for the license-out, further development, GMP material supply  and/or tech transfer.